Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Harryx who wrote (1011)	3/17/1998 8:27:00 AM
From: the Chief	Read Replies (1) \| Respond to of 8117

Hi Harryx. "For your info" was not intended to undermine your statement. If you took it that way, I apologize. However, I most enphatically disagree with your assesment of multiples, when it comes to Bio/Pharma stocks. I will gladly furnish you with the names of 7 Bio/Pharma firms listed in the US, in exactly the same stage as 3 Bio/Pharma firms that are listed on the Can market including the TSE. In all 7 cases, the market cap for junior Bio/Pharma companies on the US boards has produced an average market cap of $75mm to 125mm. In the 3 cases in Canada, the market cap is $7-22mm This is not ferry tale this is in fact, a fact. Because I am spending the winter in Florida right now, I don't have the list with me. However, if you call IGT Pharmaceutical at 1-800-743-7444 and ask for Jeff Murdock, I am sure he will enlighten you. If you had read my entire post what I intimated was that if we were looking for a quick, jump in price its NASDAQ. If we are looking for linear growth (which is a more logical approach) then TSE!! It was then I included the statement, on it depends on your greed level. For every "poor" example ie. Bre-X I can give you a superb example of the opposite "Nova Corp (NVA-TSE) "in the beginning". It is a fact, that exposure to the TSE has tremendous credibility. But, it is equally a fact, that there are many investors in the US that will not, or can not, buy stocks that are not listed on a US exchange. The market in the US is almost 600 million . The market for Canada (TSE) is estimated to be 1/4 of that. Insinuating that about 25% of active US traders trade on the TSE, with the remainder being overseas. Numbers are from the TSE, not mine!!! HERE is the message I posted: >>>Hi Harryx. The advantage of going "offshore" is the multiple accrued by being in an American environment. For your info; TSE is a large leap from VSE. VSE to NASDAQ is a small leap. In the interest of a "quick esculating price" the NASDAQ is the way to go. In the interest of a linear progressive price reflecting company worth, TSE is the answer. It is directly proportional to Greed, which one a person prefers<<< I see nothing wrong with my post. Again, if you took offence to the term "for your info" I apologize. However, I stick by my "misleading" info and suggest you call that 1-800 number. I didn't say ALL typs of companies benefit from NASDAQ listings. I am referring to Junior Bio/Pharma's and stick by that. I also was making a statement of "value of shares being directly proportional to greed" and it "depends on which one a person prefers". I never made a preference from my perspective. I was making a general info statement, that I stick by. Their is nothing misleading in that post, just fact. respectfully the Chief